column
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
Xiaojing Qin, Wenjing Ning, Han Liu, Xue Liu, Wenxin Luo, Ningshao Xia,
2024, 14(6):2361-2377. DOI:10.1016/j.apsb.2024.03.027
Abstract
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
Zhenwei Zhang, Linghui Hou, Dan Liu, Shenglin Luan, Min Huang, Linxiang Zhao,
2024, 14(6):2378-2401. DOI:10.1016/j.apsb.2024.02.010
Abstract
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, Lian Wang, Xiaoyun Wang, Xiang Li, Gu He,
2024, 14(6):2402-2427. DOI:10.1016/j.apsb.2024.01.010
Abstract
Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms
Ting Sun, Huanxin Zhao, Luyao Hu, Xintian Shao, Zhiyuan Lu, Yuli Wang, Peixue Ling, Yubo Li, Kewu Zeng, Qixin Chen,
2024, 14(6):2428-2446. DOI:10.1016/j.apsb.2024.01.018
Abstract
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
Yunmeng Liu, Yaxin Wang, Jincheng Zhang, Qikai Peng, Xingdong Wang, Xiyue Xiao, Kai Shi,
2024, 14(6):2447-2474. DOI:10.1016/j.apsb.2024.03.019
Abstract
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
Ahmed O. Elzoghby, Omar Samir, Hagar E. Emam, Ahmed Soliman, Riham M. Abdelgalil, Yomna M. Elmorshedy, Kadria A. Elkhodairy, Mahmoud L. Nasr,
2024, 14(6):2475-2504. DOI:10.1016/j.apsb.2024.03.022
Abstract
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein
Xiafei Wei, Yuzheng Zhou, Xiaotong Shen, Lujie Fan, Donglan Liu, Xiang Gao, Jian Zhou, Yezi Wu, Yunfei Li, Wei Feng, Zheng Zhang,
2024, 14(6):2505-2519. DOI:10.1016/j.apsb.2024.03.009
Abstract
Interferon-induced MXB protein restricts vimentin-dependent viral infection
Dongrong Yi, Ni An, Quanjie Li, Qian Liu, Huihan Shao, Rui Zhou, Jing Wang, Yongxin Zhang, Ling Ma, Fei Guo, Xiaoyu Li, Zhenlong Liu, Shan Cen,
2024, 14(6):2520-2536. DOI:10.1016/j.apsb.2024.03.029
Abstract
Transient induction of actin cytoskeletal remodeling associated with dedifferentiation, proliferation, and redifferentiation stimulates cardiac regeneration
Wenbin Fu, Qiao Liao, Yu Shi, Wujian Liu, Hongmei Ren, Chunmei Xu, Chunyu Zeng,
2024, 14(6):2537-2553. DOI:10.1016/j.apsb.2024.01.021
Abstract
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK-STAT pathway
Jingyi Tan, Jiayu Zhang, Cheng Hu, Gongwei Wang, Qianyao Ren, Chaoqun Wang, Jia Dan, Zexin Zeng, Jun Hu, Wenbo Zhu, Jiankai Liang, Jing Cai, Ying Liu, Guangmei Yan, Yuan Lin,
2024, 14(6):2554-2566. DOI:10.1016/j.apsb.2024.03.007
Abstract
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element
Hongying Li, Jianrui Li, Jiayu Li, Hu Li, Xuekai Wang, Jing Jiang, Lei Lei, Han Sun, Mei Tang, Biao Dong, Weiqing He, Shuyi Si, Bin Hong, Yinghong Li, Danqing Song, Zonggen Peng, Yongsheng Che, Jian-Dong Jiang,
2024, 14(6):2567-2580. DOI:10.1016/j.apsb.2024.02.023
Abstract
Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis
Hongliang Qiu, Sihui Huang, Yuting Liu, Libo Liu, Fengming Guo, Yingying Guo, Dan Li, Xianfeng Cen, Yajie Chen, Meng Zhang, Yan Che, Man Xu, Qizhu Tang,
2024, 14(6):2581-2597. DOI:10.1016/j.apsb.2024.03.015
Abstract
Allosterically activating SHP2 by oleanolic acid inhibits STAT3–Th17 axis for ameliorating colitis
Jinbo Hu, Wen Liu, Yi Zou, Chenyang Jiao, Jiazhen Zhu, Qiang Xu, Jianjun Zou, Yang Sun, Wenjie Guo,
2024, 14(6):2598-2612. DOI:10.1016/j.apsb.2024.03.017
Abstract
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
Xuemin He, Siying Wen, Xixiang Tang, Zheyao Wen, Rui Zhang, Shasha Li, Rong Gao, Jin Wang, Yanhua Zhu, Dong Fang, Ting Li, Ruiping Peng, Zhaotian Zhang, Shiyi Wen, Li Zhou, Heying Ai, Yan Lu, Shaochong Zhang, Guojun Shi, Yanming Chen,
2024, 14(6):2613-2630. DOI:10.1016/j.apsb.2024.03.011
Abstract
Computer-aided molecular design and optimization of potent inhibitors disrupting APC-Asef interaction
Xuefei Wang, Zeqian Du, Yuegui Guo, Jie Zhong, Kun Song, Junyuan Wang, Jianqiang Yu, Xiuyan Yang, Chen-Ying Liu, Ting Shi, Jian Zhang,
2024, 14(6):2631-2645. DOI:10.1016/j.apsb.2024.03.020
Abstract
Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-α inhibitors with unprecedented chemical architectures
Yulin Duan, Weiguang Sun, Yongqi Li, Zhengyi Shi, Lanqin Li, Yeting Zhang, Kun Huang, Zhiping Zhang, Changxing Qi, Yonghui Zhang,
2024, 14(6):2646-2656. DOI:10.1016/j.apsb.2024.02.002
Abstract
(+)/(-)-Gerbeloid A, a pair of unprecedented coumarin-based polycyclic meroterpenoid enantiomers from Gerbera piloselloides: Structural elucidation, semi-synthesis, and lipid-lowering activity
Chenxu Zhao, Jingrong Li, Yue Hu, Lingyu Li, Meng Yu, Yunfeng Huang, Tao Zhang, Hai Shang, Zhongmei Zou,
2024, 14(6):2657-2668. DOI:10.1016/j.apsb.2024.03.035
Abstract
An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis
Jamie Anne Lugtu-Pe, Xuning Zhang, Sako Mirzaie, Hao Han R. Chang, Nour AL-Mousawi, Kuan Chen, Yongqiang Li, Anil Kane, Daniel Bar-Shalom, Xiao Yu Wu,
2024, 14(6):2669-2684. DOI:10.1016/j.apsb.2024.03.026
Abstract
Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer
Fangyan Gao, Yueyao Wu, Runtian Wang, Yuhui Yao, Yiqiu Liu, Lingling Fan, Jingtong Xu, Jian Zhang, Xin Han, Xiaoxiang Guan,
2024, 14(6):2685-2697. DOI:10.1016/j.apsb.2024.03.012
Abstract
Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases
Xueming Xu, Yuanfeng Han, Jiali Deng, Shengfeng Wang, Shijie Zhuo, Kai Zhao, Wenhu Zhou,
2024, 14(6):2698-2715. DOI:10.1016/j.apsb.2024.03.003
Abstract
Suppressing Wnt signaling of the blood-tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases
Yang Tong, Pei An, Puxian Tang, Rui Mu, Yuteng Zeng, Hang Sun, Mei Zhao, Ziyan Lv, Pan Wang, Wanjun Han, Chunshan Gui, Xuechu Zhen, Liang Han,
2024, 14(6):2716-2731. DOI:10.1016/j.apsb.2024.03.024
Abstract
Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits
Bo Xiao, Yuqi Liang, Ga Liu, Lingshuang Wang, Zhan Zhang, Libin Qiu, Haiting Xu, Sean Carr, Xiaoxiao Shi, Rui L. Reis, Subhas C. Kundu, Zhenghua Zhu,
2024, 14(6):2732-2747. DOI:10.1016/j.apsb.2024.02.008
Abstract
Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma
Hua-yang Fan, Ming-da Zhao, Hong-jie Jiang, Zhen-wei Yu, Yu-jiang Fan, Xin-hua Liang, Ya-ling Tang, Yong Sun,
2024, 14(6):2748-2760. DOI:10.1016/j.apsb.2024.02.009
Abstract
Di-PEGylated insulin: A long-acting insulin conjugate with superior safety in reducing hypoglycemic events
Zhipeng Zeng, Runcheng Tan, Shi Chen, Haolin Chen, Zhijia Liu, Lixin Liu, Mingqiang Li, Yongming Chen,
2024, 14(6):2761-2772. DOI:10.1016/j.apsb.2024.02.022
Abstract
Genome mining of sulfonated lanthipeptides reveals unique cyclic peptide sulfotransferases
Meng Wang, Wen-Wei Li, Zhe Cao, Jianong Sun, Jiang Xiong, Si-Qin Tao, Tinghong Lv, Kun Gao, Shangwen Luo, Shi-Hui Dong,
2024, 14(6):2773-2785. DOI:10.1016/j.apsb.2024.02.016
Abstract
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier
Qiyu Tang, Guo Zhao, Hong Fang, Yale Jiang, Peiwen Ma, Jiawei Zhou, Dongyan Liu, Shujun Xing, Gaoquan Li, Nian Liu, Huiyu Chen, Shuhang Wang, Ning Li,
2024, 14(6):2786-2789. DOI:10.1016/j.apsb.2024.03.023
Abstract
Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]
Pengzhao Shang, Rui Gao, Yijia Zhu, Xiaorui Zhang, Yang Wang, Minji Guo, Hui Peng, Min Wang, Juan Zhang,
2024, 14(6):2790-2790. DOI:10.1016/j.apsb.2024.02.014
Abstract
Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ [Acta Pharm Sin B 14 (2024) 1605–1623]
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen,
2024, 14(6):2791-2793. DOI:10.1016/j.apsb.2024.04.008
Abstract